Latest Breaking News On - Ophthalmic pharmaceuticals - Page 3 : comparemela.com

Head to Head Comparison: Coloplast A/S (OTCMKTS:CLPBY) vs Bausch + Lomb (NYSE:BLCO)

Head to Head Comparison: Coloplast A/S (OTCMKTS:CLPBY) vs Bausch + Lomb (NYSE:BLCO)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomSensura mioSensura ostomyOphthalmic pharmaceuticalsLomb corporationBausch health companies incGet free reportGiven bauschChronic careContinence careRespiratory careInterventional urologyAdvanced wound careConveen activePeristeen plus

Hovering Around 52-Week Low, Bausch + Lomb May Be Poised For A Rebound (NYSE:BLCO)

Hovering Around 52-Week Low, Bausch + Lomb May Be Poised For A Rebound (NYSE:BLCO)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Justin sullivanWarren buffettBausch lombBausch health companiesBausch healthOphthalmic pharmaceuticalsValeant to buy bauschLomb forParagon biotech

Bausch + Lomb (NYSE:BLCO) Hits New 1-Year Low at $14 14

Bausch + Lomb Co. (NYSE:BLCO – Get Free Report)’s share price reached a new 52-week low during trading on Thursday . The company traded as low as $14.14 and last traded at $14.26, with a volume of 71752 shares traded. The stock had previously closed at $14.29. Analysts Set New Price Targets A number of […]

Stifel nicolausLomb company profileBarclays plcLomb coRoyal bankTower research capitalOphthalmic pharmaceuticalsSwift groupLomb corporationGet free reportLomb stock downResearch capitalBlack swift groupLomb companyVision careLomb daily

Brokerages Set Bausch + Lomb Co (NYSE:BLCO) PT at $19 18

Bausch + Lomb Co. (NYSE:BLCO – Get Free Report) has been assigned a consensus recommendation of “Hold” from the ten brokerages that are currently covering the firm, Marketbeat.com reports. Six investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 1-year price target […]

Stifel nicolausRoyal bankLomb company profileLomb coMorgan stanleyOphthalmic pharmaceuticalsNorges bankAlberta investment management corpMaple rock capital partners incLomb corporationGet free reportLomb stockRock capital partnersInvestment management corpLaurion capital managementCapital management

Bausch + Lomb Co (NYSE:BLCO) Given Average Rating of Hold by Brokerages

Bausch + Lomb Co (NYSE:BLCO) Given Average Rating of Hold by Brokerages
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Stifel nicolausSwift groupTower research capitalRoyal bankLomb coOphthalmic pharmaceuticalsLomb corporationBarclays plcGet free reportResearch capitalBlack swift groupLomb priceGet freeVision careLomb daily